Insider Transactions

Hsenghung Hsu, a director at Fastenal (FAST), recently started a stake at the company with a 2,000 share buy. The buy came to just over $88,000. This follows on a 550 share buy from another director back in September. Prior to that, insiders have been sellers throughout the year, at prices as much as 12 percent higher than where shares currently trade. The buy comes after a rally that boosted the company’s shares by 18 percent in the past year. Overall, insiders ...
Read More

Michael Barns, Executive Chairman and a major holder at Tiptree (TIPT), recently added 6,104 shares to his holdings. The buy came to just under $32,000. He followed up with a buy on Tuesday of 4,954 shares. Barnes has been a regular buyer of shares over the past few weeks, and his holdings have crept up from 8.55 million shares to over 8.60 million. The buys have occurred as shares have slid nearly 30 percent in the past year for the specialty insurance ...
Read More

Richard Glasier, a director at Carnival Corp (CCL), recently picked up 10,000 shares. The purchase came to just over $140,000, and increased the director’s stake by 23 percent. This marks the second insider buy of 2020, following a 1.25 million share buy from another director back in early April. Insiders were last sellers in 2019, at prices 70-75 percent higher than where shares currently trade. Shares of the cruise line company have doubled off their March lows. They are still down two-thirds ...
Read More

Lew Jacobs, a director at Citigroup (C), recently added 10,000 shares. The buy came to just over $440,000, and increased the director’s stake by 77 percent. He now owns over 22,900 shares. The trade marks the first move by insiders since August 2019. Insiders have mostly been sellers in the past two years, but have been inactive for a prolonged time. The last sales were at prices 30-37 percent higher than where shares currently trade. The big banks have had to contend ...
Read More

Luke Evnin, a director at Oncorus (ONCR), recently added 151,225 shares to his holdings. The value came to over $2.2 million. But he’s hardly alone. A number of funds with substantial holdings have also been adding to their stake here. That includes a 1 million share buy from Deerfield Management, and a 325,000 share buy from Gadicke Ansbert, a major holder. The buys occurred in early October, just a few weeks after the company went public. Oncorus is a clinical-stage biotech firm. Their ...
Read More

Daniel Solomita, President and CEO of Loop Industries (LOOP), recently bought 10,000 shares. The buy increased his stake by 5 percent, and came to a cost of just over $73,000. He was joined by the company CFO, buying 5,000 shares. Two directors have also been buyers in recent days, each picking up 10,000 shares in the low $8 range. This cluster of insider buying has occurred as shares have been cut nearly in half in the past month. The last insider activity ...
Read More

Ares Trading, already a major holder in Precigen (PGEN), recently added another $25 million investment. At that price, the company was able to pick up 6,758,400 shares. That’s a 32 percent increase to the fund’s stake in the company. The move dwarfs the insider sales in the past month from company insiders. The buy comes as shares of the company have dropped from $15 to under $4 in the past two years. Insiders, including Ares Trading, own over 15 percent of ...
Read More

Timothy Springer, a director and major owner at Selecta Biosciences (SELB), recently bought 3,185,394 shares of the company. That trade came to over $5.4 million. The buy increased his total holdings to just over 16.05 million shares. Another director made a 50,000 share buy at the start of October as well. There have been some insider sales in the past year, but they have been dwarfed by insider buys. Insiders own 17 percent of all shares of the immunogenetics company. Shares of ...
Read More